Uncategorized

Emicizumab (ACE910) a new treatment for haemophilia patients has now recently been approved by the US Food and Drug Administration (FDA) under the trade name […]

Samples for PT and Factors II, V, VII, and X (n=4) were tested immediately post collection, then every 2 hours until 8 hours, and again […]

A full thrombophilia screen consists of Lupus Anticoagulant, Antithrombin, Protein C, Protein S and Activated Protein C (APC) Resistance assays. These assays were tested within […]

Samples for APTT and Factors VIII, IX and XI were tested for a baseline level, re-tested at 2 hour intervals until 8 hours, and again […]

Direct oral anticoagulants are a relatively new collection of drugs which directly inhibit a single factor in the haemostatic pathway. DOACs can be split into […]